Ontology highlight
ABSTRACT: Introduction
Insulin and insulin-like growth factor type 1 (IGF1) regulate multiple physiological functions by acting on the insulin receptor (IR) and insulin-like growth factor type 1 receptor (IGF1R). The insulin analog glargine differs from insulin in three residues (GlyA21, ArgB31, ArgB32), and it is converted to metabolite M1 (lacks residues ArgB31 and ArgB32) by in vivo processing. It is known that activation of these receptors modulates pathways related to metabolism, cell division, and growth. Though, the structures and structural basis of the glargine interaction with these receptors are not known.Aim
To generate predictive structural models, and to analyze the drug/receptor interactions in the system fo
SUBMITTER: Gonzalez-Beltran M
PROVIDER: S-EPMC8477355 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature